Back
MediPharm Labs Corp. 10K Form
Buy
62
LABS.TO
MediPharm Labs Corp.
Last Price:
$0.08
Seasonality Move:
-4.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LABS.TO News And Ratings
See the #1 stock for the next 7 days that we like better than LABS.TO
LABS.TO Financial Statistics
Sales & Book Value
| Annual Sales: | $42M |
|---|---|
| Cash Flow: | $-127K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.09 |
| Price / Book: | 0.83 |
Profitability
| EPS (TTM): | -0.01930 |
|---|---|
| Net Income (TTM): | $-8M |
| Gross Margin: | $11.3M |
| Return on Equity: | -19.19% |
| Return on Assets: | -15.58% |
MediPharm Labs Corp. Earnings Forecast
Key MediPharm Labs Corp. Financial Ratios
-
The Gross Profit Margin over the past 7 years for LABS.TO is 26.94%.
-
The Selling, General & Administrative Expenses for LABS.TO have been equal to 50.87% of Gross Profit Margin.
-
The Research & Development expenses have been 0.56% of Revenue.
-
The Net Earning history of LABS.TO is -25.49% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 5 years.
MediPharm Labs Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSX |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LABS.TO |
| Website: | medipharmlabs.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 3.2 |
| Quick Ratio: | 1.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LABS.TO Technical Analysis vs Fundamental Analysis
Buy
62
MediPharm Labs Corp. (LABS.TO)
is a Buy
Is MediPharm Labs Corp. a Buy or a Sell?
-
MediPharm Labs Corp. stock is rated a BuyThe current MediPharm Labs Corp. [LABS.TO] share price is $0.08. The Score for LABS.TO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.